Biomarker

Guan M, Chang L. Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use. Gastroenterol Clin North Am. 2026 Mar;55(1):91-105. doi: 10.1016/j.gtc.2025.08.002. Epub 2025 Oct 21.[...]

By afschroeder • January 26, 2026

Snead CM, Zheng D, Ngo-Metzger Q, Gould MK. Multicancer Detection Assays: Promise and Potential Harms of a Novel Cancer Screening Tool. Perm J. 2026 Jan[...]

By afschroeder • January 14, 2026

Kankaria R, Charla JN, Ye K, Slipczuk L, Dey D, Levsky JM, Guzman W, Amadeo D, Zaidi A, Kizer JR, Barzilai N, Milman S, Bortnick[...]

By afschroeder • January 14, 2026

Bromberg JS, Bunnapradist S, Demko ZP, Gauthier P. Letter to the Editor re: Valenzuela et al. 2025 STAR working group report on dd-cfDNA validation. Am[...]

By afschroeder • January 11, 2026

Abbas N, Budoff M, Lakshmanan S. Imaging Inflammation: Epicardial Fat Density as an Imaging Marker of Cardiovascular Risk. Heart Int. 2025 Nov 24;19(2):29-34. doi: 10.17925/HI.2025.19.2.4.[...]

By afschroeder • December 12, 2025

La Cava A, Castaldo G. Editorial: Cholesterol, inflammation and immunity. Front Immunol. 2025 Sep 17;16:1696770. doi: 10.3389/fimmu.2025.1696770. PMID: 41041333; PMCID: PMC12483860.

By afschroeder • October 3, 2025

Anderson KG, Ribas A. Neoadjuvant PD-1 blockade: a new treatment option for patients with early-stage mismatch repair deficient solid tumors. J Immunother Cancer. 2025 Aug[...]

By afschroeder • August 26, 2025

Singal AG, Quirk L, Boike J, Chernyak V, Feng Z, Giamarqo G, Kanwal F, Ioannou GN, Manes S, Marrero JA, Mehta N, Pillai A, Shaheen[...]

By afschroeder • August 21, 2025

Yen YT, Zhao C, Gao T, Yang JZ, Kang N, Pu J, Qiu L, Hu Q, Kim H, Wang A, Lee J, Zhang RY, Liu[...]

By afschroeder • August 14, 2025

Tereshchenko LG, Manyara AM, Ciani O, Sodeke SO, Bradford CN, Santangeli P, Kapadia SR, Wazni O, Narayan SM, Chugh SS, Bilchick K, Huizar JF, Vaseghi[...]

By afschroeder • August 3, 2025